Home
Immunovaccine, Inc.

Immunovaccine, Inc. Market Share Analysis for February 2026

category: internet, this is an automatically generated default server page successfully deployed by (mt) media temple web hosting.

Health > Biotechnology and Pharmaceuticals

Domainimvaccine.com

Year Founded2000

Employees51 - 200

Annual Revenue< $1M

Immunovaccine, Inc.

Immunovaccine, Inc. (including company regionals)

imvaccine.com

See more website traffic and engagement information

Total visits to Immunovaccine, Inc.'s top domains

Understand Immunovaccine, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Immunovaccine, Inc.'s top domains

Analyze Immunovaccine, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Immunovaccine, Inc.'s top domains

See how Immunovaccine, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Immunovaccine, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Immunovaccine, Inc.

These are the website technologies, by industry, used by Immunovaccine, Inc. top domains

Email Services (2)

Microsoft Exchange Online

Mobile (1)

Meta Viewport

News & Signals from Immunovaccine, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsImvaccine is developing experimental vaccine on Dec 31st '20.* Nova Scotia's IMV Inc was awarded more than C$3 million to develop its experimental vaccine, which could go into trials before the end of 2020.

NewsImvaccine recognized as 2018 OTCQX® Best 50 on Jan 24th '18.Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that it has been named to the 2018 OTCQX® Best 50, a ranking of top performing companies traded on the OTCQX Best Market last year.

NewsImvaccine hired Joseph Sullivan as Senior Vice President, Business Development on Jan 22nd '18.Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF ), a clinical stage immuno-oncology company, today announced that it has appointed Joseph Sullivan to the newly created role of Senior Vice President, Business Development, effective January 22, 2018.